SPECIFIC MONOGRAPH TECHNETIUM ( 99M TC) SUCCIMER INJECTION

Size: px
Start display at page:

Download "SPECIFIC MONOGRAPH TECHNETIUM ( 99M TC) SUCCIMER INJECTION"

Transcription

1 SPECIFIC MONOGRAPH TECHNETIUM ( 99M TC) SUCCIMER INJECTION Dr Thomas Rühl RFC & MPharm Aljosa Stankovic University Hospital Clinical Center Banja Luka Thursday, September 10,

2 European Pharmacopoeia (PhEur) PhEur is a single reference work for the quality control of medicines in the member states of the PhEur Convention and the EU. 2

3 PhEur 8 th Edition Content 00 Introduction 01 General notices 02 Methods of Analysis (ph (2.2.3), UV/VIS (2.2.25), TLC (2.2.27), Sterility (2.6.1), Bacterial endotoxins (2.6.14), ) 03 Materials and Containers 04 Reagents (glacial acetic acid R , ) 05 General texts (Table of physical characteristics of radionuclides (5.07), ) 06 General monographs (Radiopharmaceutical preparations (0125),...) 07 Dosage Forms 08 Vaccines 09 Immunosera 10 Radiopharmaceutical preparations (TECHNETIUM ( 99m Tc) SUCCIMER INJECTION (0643), ) 11 Sutures 12 Herbal Drugs 13 Homeopathic preparations 14 to 17 Monographs A-Z (ACETIC ACID, GLACIAL (0590), ) 18 Index 3

4 Specific monographs Radiopharmaceutical preparations DEFINITION (all) PRODUCTION CHARACTERS (all) IDENTIFICATION (all) TESTS (all) RADIOACTIVITY (all) STORAGE LABELLING IMPURITIES (trend) 4

5 DEFINITION Sterile solution of a complex of technetium-99m with meso-2,3-dimercaptosuccinic acid. It is prepared using Sodium pertechnetate [ 99m Tc] injection (fission or non fission) (0124 or 0283). It contains: reducing substance (tin salt) stabilizers, antioxidants (ascorbic acid) inert additives Technetium-99m: 90 per cent to 110 per cent of the declared technetium-99m radioactivity at the date and time stated on the label. 99 Mo/ 99m Tc Generator 235 U(n,f)FP 99 Mo 99m Tc 99 Ru 98 Mo(n,γ) 99 Mo 99m Tc 99 Ru 5

6 CHARACTERS Appearance: clear, colourless solution.* Half-life and nature of radiation of technetium-99m: (5.7. Table of physical characteristics of radionuclides) *1.4 General Notice on Monographs: The statements under the heading Characters are not to be interpreted in a strict sense and are not requirements. 6

7 IDENTIFICATION A. Gamma-ray spectrometry. Result: technetium-99m (0.141 MeV) B. Chromatogram for radiochemical purity (Tests). Result: retardation factor radiochromatogram (R f : 0.0 to 0.1) C.*Place 1 ml of the preparation to be examined in a test-tube and add 0.1 ml of glacial acetic acid R and 1 ml of a 20 g/l solution of sodium nitroprusside R. Mix. Carefully place a layer of concentrated ammonia R at the top of the solution. A violet ring develops between the layers. RS - + [ Fe ( CN)5 NO ] 2- ( NH 3 ( a q)) [Fe ( CN)5 NOSR ] 3- * Berg et al. (1988) J. Clin, Chem. Clin. Biochem. 26,

8 TESTS ph (2.2.3): 2.3 to 3.5. Tin: maximum 1 mg/ml. Test solution. Dilute 1.5 ml of the preparation to be examined to 25.0 ml 103 g/l solution of hydrochloric acid R. Reference solution: g of stannous chloride R in a 103 g/l solution of hydrochloric acid R and dilute to ml. 1.0 ml of each solution add thioglycollic acid R, dithiol reagent R, 20 g/l solution of sodium laurilsulfate R and 21 g/l solution of hydrochloric acid R. Mix. Stand for 60 min. Measure the absorbance ((UV/VIS)2.2.25) of each solution at 540 nm (21 g/l solution of hydrochloric acid R as the compensation liquid) The absorbance of the test solution is not greater than that of the reference solution. 8

9 TESTS Physiological distribution. Inject a volume (0.2 ml) and containing not more than 0.1 mg of dimercaptosuccinic acid into a suitable vein (caudal vein) 3 rats each weighing g Measure the radioactivity in the syringe before and after the injection. Euthanise the rats 1 h after the injection. Remove the kidneys, the liver, the stomach, the lungs and, the tail (caudal vein) Determine the percentage of radioactivity In not fewer than 2 of the 3 rats used, the radioactivity is: - in the kidneys: minimum 40 per cent: - in the liver: maximum 10.0 per cent; - in the lungs: maximum 5.0 per cent; - in the stornach: maximum 2.0 per cent. 9

10 TESTS Sterility. It complies with the test for sterility prescribed in the monograph Radiopharmaceutical preparations (0125) membrane filtration The preparation may be released for use before completion of the test. 10

11 RADIOCHEMICAL PURITY Impurity A. Thin-layer chromatography (2.2.27). Plate: TLC silicagel plate R; use silica gel plate as the coating substance on a glass-fibre sheet, heated at 110 C for 10 min. Mobilephase: methyl ethyl ketone R. Application: 5-10 µl Development: immediately, over a path of cm (10 min) Drying: in air Detection: suitable detector R f values: [ 99m Tc]technetium succimer = 0.0 to 0.1; impurity A = 0.9 to 1.0. Limits: - [ 99m Tc]technetium succimer: minimum 95.0% - impurity A: maximum 2.0% 11

12 RADIOACTIVITY Determine the radioactivity using a calibrated instrument 12

13 STORAGE Protected from light 13

14 IMPURITIES IMPURITY A. [ 99m Tc]pertechnetate ion 14

15 THANK YOU FOR YOUR ATTENTION!!!! 15

SODIUM PERTECHNETATE ( 99m Tc) INJECTION (FISSION): Revised Final text for addition to The International Pharmacopoeia (January September 2009)

SODIUM PERTECHNETATE ( 99m Tc) INJECTION (FISSION): Revised Final text for addition to The International Pharmacopoeia (January September 2009) September 2009 RESTRICTED SODIUM PERTECHNETATE ( 99m Tc) INJECTION (FISSION): Revised Final text for addition to The International Pharmacopoeia (January September 2009) [Note from the Secretariat: This

More information

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009)

FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009) January 2009 FLUDEOXYGLUCOSE ( 18 F) INJECTION: Final text for addition to The International Pharmacopoeia (January 2009) This monograph was adopted at the Forty-third WHO Expert Committee on Specifications

More information

Guide for the elaboration of monographs on RADIO PHARMACEUTICAL PREPARATIONS

Guide for the elaboration of monographs on RADIO PHARMACEUTICAL PREPARATIONS Guide for the elaboration of monographs on RADIO PHARMACEUTICAL PREPARATIONS European Pharmacopoeia EDQM Edition 2018 Guide for the elaboration of monographs on RADIO PHARMACEUTICAL PREPARATIONS European

More information

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008)

ARTEMETHER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008) July 2008 ARTEMETER AND LUMEFANTRINE TABLETS: Final text for addition to The International Pharmacopoeia (July 2008) This monograph was adopted at the Forty-second W Expert Committee on Specifications

More information

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009)

NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009) February 2009. NEVIRAPINE ORAL SUSPENSION Final text for addition to The International Pharmacopoeia (February 2009) This monograph was adopted at the Forty-third WHO Expert Committee on Specifications

More information

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008)

ARTEMETHER AND LUMEFANTRINE ORAL SUSPENSION:Final text for addition to The International Pharmacopoeia (November 2008) November 2008 ` ARTEMETER AND LUMEFANTRINE RAL SUSPENSIN:Final text for addition to The International Pharmacopoeia (November 2008) Category. Antimalarial. Storage. Artemether and lumefantrine oral suspension

More information

MEDROXYPROGESTERONE INJECTION

MEDROXYPROGESTERONE INJECTION September 2011 RESTRICTED DRAFT PROPOSAL FOR The International Pharmacopoeia MEDROXYPROGESTERONE INJECTION (September 2011) DRAFT FOR COMMENT Should you have any comments on the attached draft proposal,

More information

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE December 2008 CYCLOSERINE Final text for addition to The International Pharmacopoeia (November 2008) This monograph was adopted at the Forty-third WHO Expert Committee on Specifications for Pharmaceutical

More information

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ].

BRIEFING. (EXC: K. Moore.) RTS C Propylparaben C 10 H 12 O Benzoic acid, 4 hydroxy, propyl ester; Propyl p hydroxybenzoate [ ]. BRIEFING Propylparaben. The European Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Propylparaben monograph, as part of the process

More information

LUMEFANTRINUM LUMEFANTRINE

LUMEFANTRINUM LUMEFANTRINE July 2008 LUMEFANTRINE: Final text for addition to The International Pharmacopoeia (July 2008) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications for Pharmaceutical Preparations

More information

Dehydrated Alcohol. » Dehydrated Alcohol contains not less than 99.2 percent, Pharmacopeial Forum Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847

Dehydrated Alcohol. » Dehydrated Alcohol contains not less than 99.2 percent, Pharmacopeial Forum Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847 Vol. 30(5) [Sept. Oct. 2004] HARMONIZATION 1847 The total of all other impurities in the chromatogram obtained with Test solution B: not more than the area of the peak due to 4-methylpentan-2-ol in the

More information

EFAVIRENZ Final text for addition to The International Pharmacopoeia

EFAVIRENZ Final text for addition to The International Pharmacopoeia Document QAS/05.145/FIAL March 07 EFAVIREZ Final text for addition to The International Pharmacopoeia This monograph was adopted at the Fortieth W Expert ommittee on Specifications for Pharmaceutical Preparations

More information

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS

GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS GUACO FOR HOMOEOPATHIC PREPARATIONS Mikania guaco ad praeparationes homoeopathicas DEFINITION Dried leaf of Mikania guaco H. et B. (Mikania amara Willd.). Content: minimum

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS European Medicines Agency Inspections London, 26 November 2008 Doc. Ref. EMEA/CHMP/QWP/306970/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) GUIDELINE ON RADIOPHARMACEUTICALS DRAFT AGREED BY QWP September

More information

Radiopharmacy quality control

Radiopharmacy quality control Radiopharmacy quality control P. Maltby, Liverpool (UK) 1. INTRODUCTION The overwhelming majority of radiopharmaceuticals used for diagnosis and therapy in Nuclear Medicine are administered to patients

More information

RADIOPHARMACEUTICALS METHODS OF ANALYSIS. September Revised Draft for adoption

RADIOPHARMACEUTICALS METHODS OF ANALYSIS. September Revised Draft for adoption September 2008 RESTRICTED RADIOPHARMACEUTICALS METHODS OF ANALYSIS September 2008 Revised Draft for adoption World Health Organization 2008 All rights reserved. This draft is intended for a restricted

More information

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Loss on drying Readily carbonizable substances BRIEFING Saccharin, NF 22 page 2825 and page 1711 of PF 29(5) [Sept. Oct. 2003]. The United States Pharmacopeia is the coordinating pharmacopeia for the international harmonization of the compendial standards

More information

ECD PRODUCT SPECIFICATION L,L-Ethyl cysteinate dimer

ECD PRODUCT SPECIFICATION L,L-Ethyl cysteinate dimer ECD PRODUCT SPECIFICATION ---------------------------- Generic name : Chemical name : Bicisate L,L-Ethyl cysteinate dimer Product code number : RC035 Description : L,L-Ethyl cysteinate dimer kit is a sterile,

More information

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance Niacin Extended-Release Tablets Type of Posting Posting Date Official Date Expert Committee Reason for Revision Revision Bulletin 27 Jan 2017 01 Feb 2017 Non-Botanical Dietary Supplements Compliance In

More information

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph.

The Isosorbide Mononitrate Extended-Release Tablets Revision Bulletin supersedes the currently official monograph. Isosorbide Mononitrate Extended-Release Tablets Type of Posting Revision Bulletin Posting Date 5 Oct 2018 Official Date 8 Oct 2018 Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

More information

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance Niacin Extended-Release Tablets Type of Posting Posting Date Official Date Expert Committee Reason for Revision Revision Bulletin 29 Dec 2017 01 Jan 2018 Non-Botanical Dietary Supplements Compliance In

More information

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text. Isosorbide Mononitrate Extended-Release Tablets Type of Posting Posting Date Targeted Official Date Notice of Intent to Revise 28 Sep 2018 To Be Determined, Revision Bulletin Expert Committee Chemical

More information

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph. Nitrofurantoin Capsules Type of Posting Revision Bulletin Posting Date 25 May 2018 Official Date 01 Jun 2018 Expert Committee Chemical Medicines Monographs 1 Reason for Revision Compliance In accordance

More information

RADIOPHARMACEUTICALS SUPPLEMENTARY INFORMATION Final text for addition to The International Pharmacopoeia (November 2008)

RADIOPHARMACEUTICALS SUPPLEMENTARY INFORMATION Final text for addition to The International Pharmacopoeia (November 2008) November2008 RADIOPHARMACEUTICALS SUPPLEMENTARY INFORMATION Final text for addition to The International Pharmacopoeia (November 2008) This text was adopted at the Forty-third WHO Expert Committee on Specifications

More information

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007)

DOXYCYCLINE HYCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007) November 2007 DXYCYCLINE YCLATE Final text to replace published monograph in The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-first W Expert Committee on Specifications

More information

Quality Control of Radiopharmaceuticals

Quality Control of Radiopharmaceuticals Quality Control of Radiopharmaceuticals by 0. Wallen and Dr. E. Komarov (WHO) The International Pharmacopoeia published by WHO constitutes a collection of recommended specifications for pharmaceutical

More information

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Lonicera japonica Flower Dry Extract. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium ( Published on Herbal Medicines Compendium (https://hmc.usp.org) Lonicera japonica Flower Dry Extract Proposed For Development Version 0.1 Lonicera japonica Flower Dry Extract DEFINITION The article is prepared

More information

This method describes the identification of the following prohibited colorants in cosmetic products:

This method describes the identification of the following prohibited colorants in cosmetic products: A. IDENTIFICATION BY TLC 1. SCOPE AND FIELD OF APPLICATION This method describes the identification of the following prohibited colorants in cosmetic products: Names C I number Pigment Orange 5 12075 Metanil

More information

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC) Document A. THIN LAYER CHROMATOGRAPHY (TLC) 1. SCOPE AND FIELD OF APPLICATION The method describes the identification of hydrocortisone acetate, dexamethasone, betamethasone, betamethasone 17-valerate

More information

Laboratory 3: Kit Preparation and Chromatography. Design Considerations for a Radiopharmaceutical

Laboratory 3: Kit Preparation and Chromatography. Design Considerations for a Radiopharmaceutical Laboratory 3: Kit Preparation and Chromatography PART 1: KIT PREPARATION Introduction In nuclear medicine, radionuclides are rarely used in their simplest chemical form. Instead they are incorporated into

More information

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or

Should you have any questions, please contact Mary P. Koleck, Ph.D., Scientific Liaison ( or Alfuzosin Hydrochloride Extended Release Tablets Type of Posting Posting Date 27 May 2016 Official Date 01 Jun 2016 Expert Committee Chemical Medicines Monographs 5 Reason for Revision Compliance In accordance

More information

RADIOPHARMACEUTICAL PREPARATIONS Radiopharmaceutica

RADIOPHARMACEUTICAL PREPARATIONS Radiopharmaceutica Radiopharmaceutical preparations EUROPEAN PHARMACOPOEIA 5.0 such animals are included as active substances or excipients or have been used during production, for example as raw or source materials, starting

More information

Practical 1 Procedure Iron by Titrimetry

Practical 1 Procedure Iron by Titrimetry Practical 1 Procedure Iron by Titrimetry Introduction This experiment quantifies Fe 2+, ferrous iron, by reacting it with ceric sulphate in a 1:1 reaction, i.e. one mole of ferrous iron reacts with one

More information

PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS.

PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS. PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS. The principle of GMP and the detailed guidelines are applicable to all operations which

More information

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC

IDENTIFICATION AND DETERMINATION OF HYDROQUINONE IN COSMETIC PRODUCTS 2 14/11/17 ACM 003 BY TLC AND HPLC A. IDENTIFICATION BY TLC 1. SCOPE AND FIELD OF APPLICATION The method describes the identification of hydroquinone in cosmetic products. 2. PRINCIPLE Hydroquinone is identified by thin layer chromatography

More information

Lonicera japonica Flower Powder. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium (

Lonicera japonica Flower Powder. Proposed For Development Version 0.1. Published on Herbal Medicines Compendium ( Published on Herbal Medicines Compendium (https://hmc.usp.org) Lonicera japonica Flower Powder Proposed For Development Version 0.1 Lonicera japonica Flower Powder DEFINITION The article consists of the

More information

Ondansetron Hydrochloride Tablets

Ondansetron Hydrochloride Tablets Ondansetron Hydrochloride Tablets Dissolution Perform the test with 1 tablet of Ondansetron Hydrochloride Tablets at 50 revolutions per minute according to the Paddle method, using 900 ml of water

More information

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis . USP 36 Official Monographs / Metformin 4271 System suitability each of 5 s, at about 20,000 rpm, and allow to soak for Sample: System suitability solution 2 min. Repeat these steps two additional times.]

More information

[ 11 C]NNC 112 FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

[ 11 C]NNC 112 FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS 5. MANUFACTURE OF DRUG SUBSTANCE A. Batch Formula The following components and their quantities are used in the production of each batch of [ 11 C]NNC 112 for Injection: Name of component Component s function

More information

THE INTERNATIONAL PHARMACOPOEIA RADIOPHARMACEUTICALS: GENERAL MONOGRAPH REVISION. (June 2013)

THE INTERNATIONAL PHARMACOPOEIA RADIOPHARMACEUTICALS: GENERAL MONOGRAPH REVISION. (June 2013) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 THE INTERNATIONAL PHARMACOPOEIA Working document QAS/13.542 June 2013 RESTRICTED

More information

Monographs for individual radiopharmaceutical preparations (September 2007)

Monographs for individual radiopharmaceutical preparations (September 2007) September 2007 RESTRICTED Monographs for individual radiopharmaceutical preparations (September 2007) DRAFT FOR COMMENT Please send any comments on the revision of this draft document to Dr S. Kopp with

More information

Chapter 4: Verification of compendial methods

Chapter 4: Verification of compendial methods Chapter 4: Verification of compendial methods Introduction In order to ensure accurate and reliable test results, the quality control laboratory (QCL) needs to use analytical methods (and accompanying

More information

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009.

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB5009. Translated English of Chinese Standard: GB5009.17-2014 www.chinesestandard.net Sales@ChineseStandard.net NATIONAL STANDARD OF GB THE PEOPLE S REPUBLIC OF CHINA National Food Safety Standard-Determination

More information

[ 11 C]MePPEP FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

[ 11 C]MePPEP FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS 5. MANUFACTURE OF DRUG SUBSTANCE A. Batch Formula The following components and their quantities are used in the production of each batch of [ 11 C]MePPEP for Injection: Name of component Component s function

More information

Introduction to biochemical practicals. Vladimíra Kvasnicová

Introduction to biochemical practicals. Vladimíra Kvasnicová Introduction to biochemical practicals Vladimíra Kvasnicová arrangement of practicals laboratory safety regulations laboratory equipment dealing with automatic pipette instructions: http://vyuka.lf3.cuni.cz/

More information

Chromatography and Functional Group Analysis

Chromatography and Functional Group Analysis Chromatography Chromatography separates individual substances from a mixture. - to find out how many components there are - to match the components with known reference materials - to use additional analytical

More information

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min. Atorvastatin Calcium Tablets Type of Posting Posting Date 25 Jan 2019 Official Date 01 Feb 2019 Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance In accordance with the Rules

More information

Radiopharmaceuticals for Nuclear Cardiac Imaging: Generator Systems for Tc-99m and Rb-82. Charles W. Beasley, Ph.D. Associate Professor of Radiology

Radiopharmaceuticals for Nuclear Cardiac Imaging: Generator Systems for Tc-99m and Rb-82. Charles W. Beasley, Ph.D. Associate Professor of Radiology Radiopharmaceuticals for Nuclear Cardiac Imaging: Generator Systems for Tc-99m and Rb-82 Charles W. Beasley, Ph.D. Associate Professor of Radiology 1 Objectives List common SPECT MPI agents Describe preparation

More information

Introduction to Pharmaceutical Chemical Analysis

Introduction to Pharmaceutical Chemical Analysis Introduction to Pharmaceutical Chemical Analysis Hansen, Steen ISBN-13: 9780470661222 Table of Contents Preface xv 1 Introduction to Pharmaceutical Analysis 1 1.1 Applications and Definitions 1 1.2 The

More information

A. GENERAL NOTICES. Ninth Edition, which may be abbreviated as JSFA-IX.

A. GENERAL NOTICES. Ninth Edition, which may be abbreviated as JSFA-IX. A. GENERAL NOTICES A. GENERAL NOTICES 1. The title of this book is Japan s Specifications and Standards for Food Additives, Ninth Edition, which may be abbreviated as JSFA-IX. 2. Unless otherwise specified,

More information

Additionally, minor editorial changes have been made to update the monograph to current USP style.

Additionally, minor editorial changes have been made to update the monograph to current USP style. Extended-Release Tablets Type of Posting Revision Bulletin Posting Date 27 Oct 2017 Official Date 01 Nov 2017 Expert Committee Chemical Medicines Monographs 4 Reason for Revision Compliance In accordance

More information

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE Translated English of Chinese Standard: GB5009.28-2016 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net NATIONAL STANDARD OF THE GB PEOPLE S REPUBLIC OF CHINA GB 5009.28-2016

More information

TECHNOLOGY FOR PRODUCTION OF PORTABLE TC-99M GEL GENERATORS USING NEUTRON ACTIVATED NATURAL MOLYBDENUM ALMATY, REPUBLIC OF KAZAKHSTAN

TECHNOLOGY FOR PRODUCTION OF PORTABLE TC-99M GEL GENERATORS USING NEUTRON ACTIVATED NATURAL MOLYBDENUM ALMATY, REPUBLIC OF KAZAKHSTAN TECHNOLOGY FOR PRODUCTION OF PORTABLE TC-99M GEL GENERATORS USING NEUTRON ACTIVATED NATURAL MOLYBDENUM ALMATY, REPUBLIC OF KAZAKHSTAN E. CHAKROVA, V. BANNYKH, P.CHAKROV, V. KUTEPOV, I. FETSSOV INSTITUTE

More information

RADIOLOGICAL CHARACTERIZATION Laboratory Procedures

RADIOLOGICAL CHARACTERIZATION Laboratory Procedures RADIOLOGICAL CHARACTERIZATION Laboratory Procedures LORNA JEAN H. PALAD Health Physics Research Unit Philippine Nuclear Research Institute Commonwealth Avenue, Quezon city Philippines 3-7 December 2007

More information

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component)

INDIGOTINE. Disodium 3,3'-dioxo-[delta 2,2' -biindoline]-5,5'-disulfonate (principal component) (principal component) INDIGOTINE Prepared at the 73rd JEFA (2010) and published in FAO Monographs 10 (2010), superseding specifications prepared at the 28 th JEFA (1984) and published in the ombined ompendium of Food Additive

More information

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house

SPECIFICATION & TEST PROCEDURE SODIUM SALICYLATE Technical. Molecular weight : Reference : In-house Page 1 of 8 Molecular Formula : C 7 H 5 NaO 3 CAS Registry No. : [54 21 7] Molecular weight : 160.10 Reference : In-house Other names : Benzoic acid, 2 hydroxy, mono sodium salt, Mono sodium salicylate.

More information

LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator

LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator LSC2017 Conference 1-5th May, 2017, Copenhagen LSC for Quality Control of 99m TC Eluate from 99 Mo- 99m Tc Generator Xiaolin Hou Technical University of Denmark, Center for Nuclear Technologies Roskilde,

More information

Research of Quality Standards for Stachydrine Hydrochloride in Chinese Medicine TJF Granule

Research of Quality Standards for Stachydrine Hydrochloride in Chinese Medicine TJF Granule Pharmacology & Pharmacy, 2013, 4, 277-282 http://dx.doi.org/10.4236/pp.2013.43040 Published Online June 2013 (http://www.scirp.org/journal/pp) 277 Research of Quality Standards for Stachydrine Hydrochloride

More information

GENERAL PHARMACOPOEIA MONOGRAPH

GENERAL PHARMACOPOEIA MONOGRAPH MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION GENERAL PHARMACOPOEIA MONOGRAPH Colour intensity of liquids GPM.1.2.1.0006.15 Replaces the State Pharmacopoeia of the Russian Federation XII, Part 1 Monograph,

More information

Synthesis and stability of [ 77 Br]-m-Bromobenzylguanidine ( 77 Br-MBBG)

Synthesis and stability of [ 77 Br]-m-Bromobenzylguanidine ( 77 Br-MBBG) Synthesis and stability of [ 77 Br]-m-Bromobenzylguanidine ( 77 Br-MBBG) Shigeki Watanabe 1 [ watanabe.shigeki@jaea.go.jp ] Noriko S. Ishioka 1, Ji Xin Liang 1, Hirofumi Hanaoka 2, Yasuhiko iida 2,3, Keigo

More information

Thin Layer Chromatography

Thin Layer Chromatography Thin Layer Chromatography Thin-layer chromatography involves the same principles as column chromatography, it also is a form of solid-liquid adsorption chromatography. In this case, however, the solid

More information

PRODUCTION AND QUALITY CONTROL OF RADIOPHARMACEUTICALS

PRODUCTION AND QUALITY CONTROL OF RADIOPHARMACEUTICALS PRODUCTION AND QUALITY CONTROL OF RADIOPHARMACEUTICALS RAYMOND TAILLEFER, M.D. FRCP(c), ABNM DIRECTOR, DEPARTMENT OF NUCLEAR MEDICINE HOPITAL DU HAUT-RICHELIEU,CANADA Disclosures to Report: Grant Research

More information

Ester Synthesis And Analysis: Aspirin and Oil of Wintergreen. Vanessa Jones November 19, 2015 Thursday 8:30 Lab Section Lab Partner: Melissa Blanco

Ester Synthesis And Analysis: Aspirin and Oil of Wintergreen. Vanessa Jones November 19, 2015 Thursday 8:30 Lab Section Lab Partner: Melissa Blanco Ester Synthesis And Analysis: Aspirin and Oil of Wintergreen Vanessa Jones November 19, 2015 Thursday 8:30 Lab Section Lab Partner: Melissa Blanco INTRODUCTION For this lab, students attempted to synthesize

More information

Chapter 5: Identification, Assay and Related Substances

Chapter 5: Identification, Assay and Related Substances Chapter 5: Identification, Assay and Related Substances Introduction The BP, Ph.Int. and USP each has a monograph for the analysis of quinine sulfate tablets. The quantitative methods were successfully

More information

Dissolution Test 2 was validated using an Inertsil ODS-3V brand of L1 column. The typical retention time for donepezil is about 5.5 min.

Dissolution Test 2 was validated using an Inertsil ODS-3V brand of L1 column. The typical retention time for donepezil is about 5.5 min. Donepezil Hydrochloride Tablets Type of Posting Revision Bulletin Posting Date 27 Jan 2017 Official Date 01 Feb 2017 Expert Committee Chemical Medicines Monographs 4 Reason for Revision Compliance In accordance

More information

Egualen Sodium Granules

Egualen Sodium Granules Egualen Sodium Granules Dissolution Weigh accurately an amount of Egualen Sodium Granules, equivalent to about 5 mg of egualen sodium (C 15 H 17 NaO 3 S 1/3 H2O) according to the labeled amount,

More information

ORIGINAL PAPER. Introduction. Hossain Targholizadeh, Gholamreza Raisali, Amir R. Jalilian, Nima Rostampour, Mohammadreza Ensaf, Mohsen K.

ORIGINAL PAPER. Introduction. Hossain Targholizadeh, Gholamreza Raisali, Amir R. Jalilian, Nima Rostampour, Mohammadreza Ensaf, Mohsen K. NUKLEONIKA 2010;55(1):113 118 ORIGINAL PAPER Cyclotron production of technetium radionuclides using a natural metallic molybdenum thick target and consequent preparation of [Tc]-BRIDA as a radio-labelled

More information

Spectroscopy and Chromatography

Spectroscopy and Chromatography Spectroscopy and Chromatography Introduction Visible light is one very small part of the electromagnetic spectrum. The different properties of the various types of radiation depend upon their wavelength.

More information

PREPARATION AND QUALITY CONTROL OF 99m Tc-MDP

PREPARATION AND QUALITY CONTROL OF 99m Tc-MDP 2005 International Nuclear Atlantic Conference INAC 2005 Santos, SP, Brazil, August 28 to September 2, 2005 ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR ABEN ISBN: 8599141015 PREPARATION AND QUALITY CONTROL

More information

Chromatographic Methods of Analysis Section: 5 Gas Chromatography (GC) Prof. Tarek A. Fayed

Chromatographic Methods of Analysis Section: 5 Gas Chromatography (GC) Prof. Tarek A. Fayed Chromatographic Methods of Analysis Section: 5 Gas Chromatography (GC) Prof. Tarek A. Fayed Gas Chromatography (GC) In gas chromatography, the sample is vaporized and injected onto the head of a chromatographic

More information

PAPER AND THIN LAYER CHROMATOGRAPHY (TLC)

PAPER AND THIN LAYER CHROMATOGRAPHY (TLC) PAPER AND THIN LAYER CHROMATOGRAPHY (TLC) Objectives Understand the principle of Paper and Thin Layer Chromatography (TLC). Diagnose two samples of urine for Phenylketonuria and Cystinuria, using paper

More information

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text. Metformin Hydrochloride Extended-Release Tablets Type of Posting Posting Date Targeted Official Date Notice of Intent to Revise 28 Sept 2018 To Be Determined, Revision Bulletin Expert Committee Chemical

More information

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 9 DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 9 Determination of drug release during

More information

Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers.

Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers. Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers. 1 Scope This document describes a chromatographic method which allows the identification as well as the determination of

More information

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD APPENDIX V TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD Validating Chromatographic Methods. By David M. Bliesner Copyright 2006 John Wiley & Sons, Inc. 159 160 APPENDIX V Title: Effective: Document No:

More information

ALTERNATIVE METHODS FOR RADIOCHEMICAL PURITY TESTING IN RADIOPHARMACEUTICALS

ALTERNATIVE METHODS FOR RADIOCHEMICAL PURITY TESTING IN RADIOPHARMACEUTICALS 2011 International Nuclear Atlantic Conference - INAC 2011 Belo Horizonte, MG, Brazil, October 24-28, 2011 ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR - ABEN ISBN: 978-85-99141-04-5 ALTERNATIVE METHODS FOR

More information

Chemical synthesis (see also reaction scheme, bold underlined numbers in this text refer to the bold underlined numbers in the scheme)

Chemical synthesis (see also reaction scheme, bold underlined numbers in this text refer to the bold underlined numbers in the scheme) Supplementary Note This section contains a detailed description of the chemical procedures and the characterization of products. The text is followed by a reaction scheme explaining the synthetic strategies

More information

PDG.pdf G-20 CHROMATOGRAPHY 3 4 INTRODUCTION

PDG.pdf G-20 CHROMATOGRAPHY 3 4 INTRODUCTION 1 2 3 4 5 INTRODUCTION G-20 CHROMATOGRAPHY 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Chromatographic separation techniques are multi-stage separation methods in which the components

More information

USP 35 Official Monographs / Oxaliplatin 4143 DEFINITION

USP 35 Official Monographs / Oxaliplatin 4143 DEFINITION USP 35 Official Monographs / Oxaliplatin 4143 Assay preparation and the Standard preparation, respectively.. Where the test for Uniformity of dosage units has been performed using the Procedure for content

More information

Experiment 1: Extraction and Thin Layer Chromatography

Experiment 1: Extraction and Thin Layer Chromatography Experiment 1: Extraction and Thin Layer Chromatography Introduction: Chromatography is a useful tool in chemistry and can be very helpful in determining the composition of an unknown sample. In chromatography

More information

PYRIPROXYFEN TECHNICAL

PYRIPROXYFEN TECHNICAL WHO/IS/TC/715/2001 TECHNICAL TECHNICAL 1. Specification 1.1 Description Interim specification WHO/IS/TC/715/2001 The material shall consist of pyriproxyfen together with related manufacturing impurities.

More information

Manual Accompanying The GPHF-Minilab

Manual Accompanying The GPHF-Minilab A Concise Quality Control Guide On Essential Drugs And Other Medicines Manual Accompanying The GPHF-Minilab Third Supplement To Volume II Thin Layer Chromatography Extension 2003 Antiretrovirals An Initiative

More information

H 3 CO H 3 CO S CH 3

H 3 CO H 3 CO S CH 3 FENITROTHION 35 H 3 CO P H 3 CO S O CH 3 NO 2 ISO common name Chemical name Fenitrothion O,O-Dimethyl O-4-nitro-m-tolyl phosphorothioate (IUPAC) O,O-Dimethyl O-(3-methyl-4-nitrophenyl)- phosphorothioate

More information

[ 11 C](-)-RWAY FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS

[ 11 C](-)-RWAY FOR INJECTION: CHEMISTRY, MANUFACTURING AND CONTROLS 5. MANUFACTURE OF DRUG SUBSTANCE A. Batch Formula The following components and their quantities are used in the production of each batch of [ 11 C](-)- RWAY for injection: Name of component Component s

More information

Measuring Volume: Beaker. Measuring Volume. Measuring Volume: Burette. Comparison of Apparatus. Measuring Volume: Pipette 4/26/2010

Measuring Volume: Beaker. Measuring Volume. Measuring Volume: Burette. Comparison of Apparatus. Measuring Volume: Pipette 4/26/2010 Learning Objectives At the end of the lesson, you should be able to: Identify the various apparatus used in the laboratory for measurement State the accuracy of the apparatus used in the laboratory. Suggest

More information

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC. 7. Stability indicating analytical method development and validation of and in capsule dosage form by HPLC. 7.1 INSTRUMENTS AND MATERIALS USED 7.1.1 INSTRUMENTS 1. Shimadzu LC-2010 CHT with liquid chromatograph

More information

Product Description and Specification

Product Description and Specification Product Description and Specification Catalog No 7 Synthra [ 11 C]Choline Description Synthra [ 11 C]Choline is a completely automated synthesis system for routine production of [ 11 C]choline. Using in-target

More information

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description

TECHNICAL TEMEPHOS. 1. Specification. Full specification WHO/SIT/19.R4 Revised 10 December Description WHO/SIT/19.R4 TEMEPHOS TECHNICAL TECHNICAL TEMEPHOS 1. Specification 1.1 Description Full specification WHO/SIT/19.R4 Revised 10 December 1999 The material shall consist of temephos together with related

More information

Laboratory Exercise: Chromatographic Separation

Laboratory Exercise: Chromatographic Separation CHEM 109 Introduction to Chemistry Revision 1.0 Laboratory Exercise: Chromatographic Separation As we have discussed, chromatographic separations employ a system with two phases of matter; a mobile phase

More information

COMPARISON OF CHROMATOGRAPHY SYSTEMS FOR RADIOCHEMICAL PURITY DETERMINATION OF LYOPHILIZED REAGENTS LABELED WITH TECHNETIUM-99m

COMPARISON OF CHROMATOGRAPHY SYSTEMS FOR RADIOCHEMICAL PURITY DETERMINATION OF LYOPHILIZED REAGENTS LABELED WITH TECHNETIUM-99m 2009 International Nuclear Atlantic Conference - INAC 2009 Rio de Janeiro,RJ, Brazil, September27 to October 2, 2009 ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR - ABEN ISBN: 978-85-99141-03-8 COMPARISON OF

More information

Revision Bulletin Official April 1, 2014 Alprazolam 1

Revision Bulletin Official April 1, 2014 Alprazolam 1 . Apparatus Official April 1, 2014 Alprazolam 1 1: 100 rpm Alprazolam Extended-Release Tablets s: 1, 4, 8, and 12 h Mobile phase: Acetonitrile, tetrahydrofuran, and Medium (7:1:12) DEFINITION Alprazolam

More information

Chromatography & instrumentation in Organic Chemistry

Chromatography & instrumentation in Organic Chemistry Chromatography & instrumentation in Organic Chemistry What is Chromatography? Chromatography is a technique for separating mixtures into their components in order to analyze, identify, purify, and/or quantify

More information

TERTIARY BUTYLHYDROQUINONE

TERTIARY BUTYLHYDROQUINONE SYNONYMS TBHQ, INS No 319 DEFINITION TERTIARY BUTYLHYDROQUINONE Prepared at the 49th JECFA (1997), published in FNP 52 Add 5 (1997) superseding specifications prepared at the 44th JECFA (1995), published

More information

Chromatography 1 of 26 Boardworks Ltd 2016

Chromatography 1 of 26 Boardworks Ltd 2016 Chromatography 1 of 26 Boardworks Ltd 2016 Chromatography 2 of 26 Boardworks Ltd 2016 What is chromatography? 3 of 26 Boardworks Ltd 2016 Different instrumental methods can be used to analyse and identify

More information

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. NY/T Translated English of Chinese Standard: NY/T

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. NY/T Translated English of Chinese Standard: NY/T Translated English of Chinese Standard: NY/T1447-2007 www.chinesestandard.net Buy True-PDF Auto-delivery. Sales@ChineseStandard.net AGRICULTURAL INDUSTRY STANDARD NY OF THE PEOPLE S REPUBLIC OF CHINA ICS

More information

THE CATHOLIC UNIVERSITY OF EASTERN AFRICA A. M. E. C. E. A

THE CATHOLIC UNIVERSITY OF EASTERN AFRICA A. M. E. C. E. A THE CATHOLIC UNIVERSITY OF EASTERN AFRICA A. M. E. C. E. A MAIN EXAMINATION P.O. Box 62157 00200 Nairobi - KENYA Telephone: 891601-6 Fax: 254-20-891084 E-mail:academics@cuea.edu JANUARY APRIL 2014 TRIMESTER

More information

1. Preliminary qualitative analysis of unknown substances (liquid or solid).

1. Preliminary qualitative analysis of unknown substances (liquid or solid). Name of Procedure: Ultraviolet Spectroscopy Suggested Uses: 1. Preliminary qualitative analysis of unknown substances (liquid or solid). 2. Quantitative analysis of known compounds. Apparatus Used to Perform

More information

Svensk läkemedelsstandard

Svensk läkemedelsstandard Svensk läkemedelsstandard 2018.2 Acetylene intermix (1 per cent) in nitrogen Postadress/Postal address: P.O. Box 26, SE-751 03 Uppsala, SWEDEN Besöksadress/Visiting address: Dag Hammarskjölds väg 42, Uppsala

More information

Chromatographic Methods of Analysis Section 2: Planar Chromatography. Prof. Tarek A. Fayed

Chromatographic Methods of Analysis Section 2: Planar Chromatography. Prof. Tarek A. Fayed Chromatographic Methods of Analysis Section 2: Planar Chromatography Prof. Tarek A. Fayed Planar chromatography includes two types: 1- Thin Layer Chromatography (TLC). 2- Paper Chromatography (PC). Thin

More information

Abstract. Introduction

Abstract. Introduction Investigating the Techniques of Solid- Liquid Extraction by isolating lycopene from tomato paste and Column Chromatography &Thin-Layer Chromatography (TLC)by purifying lycopene Mengying Li Department of

More information